Jessica Bonilla
Primary Care · Johns Creek, GANPI 1922713676
Payments from drug & device makers
Across 76 payments — averaging $18.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$227
- AstraZeneca$204
- Novo Nordisk$194
- AbbVie$113
- Exact Sciences$112
- Noven Therapeutics, LLC$100
- plus $441 from 12 others
What the payments were for
- Food & beverage$1,391100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 13 | $227 |
| AstraZeneca | 10 | $204 |
| Novo Nordisk | 11 | $194 |
| AbbVie | 8 | $113 |
| Exact Sciences | 5 | $112 |
| Noven Therapeutics, LLC | 5 | $100 |
| Corium, LLC | 4 | $82 |
| Esperion Therapeutics, Inc. | 4 | $75 |
| Idorsia Pharmaceuticals US Inc | 4 | $66 |
| Amgen | 3 | $47 |
| Verity Pharmaceuticals Inc. | 2 | $35 |
| Regeneron Healthcare Solutions, Inc. | 1 | $27 |
| Merck | 1 | $20 |
| Pfizer | 1 | $20 |
| GSK | 1 | $18 |
| Astellas Pharma US Inc | 1 | $18 |
| Acella Pharmaceuticals, LLC | 1 | $17 |
| Dexcom, Inc. | 1 | $16 |
How this compares
$1,391 in reported general payments places this provider in the 70th percentile of 235 primary care providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Rosuvastatin Calcium | 75 | $488 |
| Atorvastatin Calcium | 82 | $420 |
| Levothyroxine Sodium | 61 | $411 |
| Diclofenac Sodium | 15 | $401 |
| Amlodipine Besylate | 60 | $389 |
| Gabapentin | 13 | $386 |
| Lisinopril-HydrochlorothiazideLisinopril/Hydrochlorothiazide | 22 | $352 |
| Metoprolol Succinate | 22 | $304 |
| Losartan Potassium | 44 | $292 |
| Metformin Hcl ErMetformin Hcl | 44 | $265 |
| Ezetimibe | 19 | $242 |
| Olmesartan Medoxomil | 13 | $240 |
| Allopurinol | 12 | $180 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 27 | $178 |
| Simvastatin | 28 | $174 |
Paid to pharmacies, not to this prescriber.
Other primary care in Johns Creek
- Pamela TurkDouglas$15K
- Morgan JonesLawrenceville$14K
- Jessi HaleColumbus$13K
- Meredith CarrAugusta$12K
- Ashtyn ZaryckiSavannah$12K
- Zanetta BryantNewnan$11K
- Hannah CummingsSuwanee$9K
- Michelle LadewigGainesville$7K
- Lucia OcanoviciuCanton$7K
- Sarah NewGrovetown$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.